![氯吡格雷与血小板反应_第1页](http://file.renrendoc.com/FileRoot1/2018-8/9/992f5a85-2b65-44af-b006-57f2cf82f1d9/992f5a85-2b65-44af-b006-57f2cf82f1d91.gif)
![氯吡格雷与血小板反应_第2页](http://file.renrendoc.com/FileRoot1/2018-8/9/992f5a85-2b65-44af-b006-57f2cf82f1d9/992f5a85-2b65-44af-b006-57f2cf82f1d92.gif)
![氯吡格雷与血小板反应_第3页](http://file.renrendoc.com/FileRoot1/2018-8/9/992f5a85-2b65-44af-b006-57f2cf82f1d9/992f5a85-2b65-44af-b006-57f2cf82f1d93.gif)
![氯吡格雷与血小板反应_第4页](http://file.renrendoc.com/FileRoot1/2018-8/9/992f5a85-2b65-44af-b006-57f2cf82f1d9/992f5a85-2b65-44af-b006-57f2cf82f1d94.gif)
![氯吡格雷与血小板反应_第5页](http://file.renrendoc.com/FileRoot1/2018-8/9/992f5a85-2b65-44af-b006-57f2cf82f1d9/992f5a85-2b65-44af-b006-57f2cf82f1d95.gif)
已阅读5页,还剩19页未读, 继续免费阅读
版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领
文档简介
CLEAR PLATELETS: Clopidogrel Loading with Eptifibatide to Arrest the Reactivity of Platelets 1 Introduction We have previously reported a significant incidence of clopidogrel resistance in patients post-elective coronary stenting treated with a standard 300-mg loading dose1 (31% at 24 hours) Patients with clopidogrel resistance/high post-stent platelet reactivity may be at greatest risk of SAT and ischemic events2-4 Relation of peri-procedural platelet reactivity to myocardial necrosis has never been prospectively studied These data suggest that 300 mg clopidogrel/75 mg qd does not provide sufficient inhibition in some patients undergoing elective coronary stenting 1. Gurbel et al. Circulation. 2003;107:2908. 2. Muller et al. Thromb Haemost. 2003;89:783. 3. Barragan et al. Catheter Cardiovasc Interv. 2003;59:295. 4. Matetzky et al. Circulation. 2004;109:3171. 2 Introduction (contd) Mechanisms of clopidogrel nonresponse/resistance are incompletely defined ? Due to inadequate levels of active metabolite ? Overcome by a higher dose Study of 30 pts (n=10 for ticlodipine, n=10 for clopidogrel 300 mg, n=10 for clopidogrel 600 mg) suggested better inhibition with 600 mg at 4 hours but no difference at 24 hours with 600-mg dose1 1. Muller et al. Heart. 2001;85:92. 3 Introduction (contd) A large prospective pharmacodynamic study of clopidogrel 300 mg vs 600 mg is not available The effect of adding eptifibatide to these regimens is unknown ISAR REACT suggested no benefit of adding abciximab to patients loaded with 600 mg clopidogrel1 Patients all pretreated for 2 hours (median 7.4 hours) Risk of bleeding with CABG in patients on clopidogrel therapy2 Low-risk group 1. Kastrati et al. N Engl J Med. 2004;350:232. 2. Hongo et al. J Am Coll Cardiol. 2002;40:231. 4 Objectives of CLEAR PLATELETS Trial Compare platelet reactivity following 4 treatments in low - to moderate-risk patients undergoing elective stenting Without pretreatment (CRUSADE) coronary anatomy unknown prior to procedure DOSING 600 mg Clopidogrel 600 mg Clopidogrel + eptifibatide 300 mg Clopidogrel 300 mg Clopidogrel + eptifibatide Analyze the relation of platelet reactivity to postprocedural myocardial necrosis Analyze the relation of platelet reactivity to postprocedural inflammation Gurbel et al. Circulation. 2005;111:1153. 5 Methods Consecutive patients undergoing elective coronary stenting Exclusion criteria Chest pain 1.5 Platelets 4.0 mg/dL Thienopyridine or GP IIb/IIIa use Elevated cardiac markers CVA 3 ULN) CKMB (1-3 ULN) CKMB (normal) Gurbel et al. Circulation. 2005;111:1153. 17 No MI MI 5 M ADP-Induced Aggregation Mean platelet reactivity (%) P0.01 Relation of Mean Posttreatment Aggregation to Occurrence of MI (n=120) No MI MI 20 M ADP-Induced Aggregation Mean platelet reactivity (%) P0.01 Gurbel et al. Circulation. 2005;111:1153. 18 CKMB ( 1- 3 X ULN ) Patients (%) CKMB ( 3X ULN ) * * *P1 - 3 ULN ) CKMB (3 ULN ) * * Patients (%) Relation of Platelet Reactivity to Myocardial Necrosis 0 10 20 30 Clopidogrel 300 mg Clopidogrel 600 mg Clopidogrel 300 mg + eptifibatide Clopidogrel 600 mg + eptifibatide *P ULN ) Myoglobin ( 2X ULN ) P = 0.08 P = 0.04 P = 0.006 P = 0.09 Gurbel et al. Circulation. 2005;111:1153. EARLY CLINICAL RELEVANCE OF PLATELET REACTIVITY: MYOCARDIAL INFARCTION 21 Troponin-I ( ULN ) Myoglobin (2 ULN ) P=0.08 P=0.04 P=0.006 P=0.09 Patients (%) Early Clinical Relevance of Platelet Reactivity: Myocardial Infarction Clopidogrel 300 mg Clopidogrel 600 mg Clopidogrel 300 mg + eptifibatide Clopidogrel 600 mg + eptifibatide 0 10 20 30 40 50 Gurbel et al. Circulation. 2005;111:1153. 0 0 22 Conclusions Platelet reactivity correlates strongly with the development of periprocedural myocardial necrosis in elective stenting When clopidogrel pretreatment is not possible or when the duration of pretreatment is inadequate, a strategy of eptifibatide administration should be considered since it is associated with superior platelet inhibition and lower myocardial necrosis than either 300 mg or 600 mg clopidogrel alone In the absence of eptifibatide, a strategy of clopidogrel 600 mg clearly provides superior platelet inhibition compared with the standard 300-mg dose A 600-mg loading dose should become t
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 2024年《建筑施工技术》7月期末试题及答案
- 2024-2025学年高中化学下学期《乙烯》教学设计
- 4 地球-我们的家园(教学设计)2023-2024学年统编版道德与法治六年级下册
- Unit4 Adversity and Courage Reading and Thinking A Successful Failure教学设计-2023-2024学年高中英语人教版(2019)选择性必修第三册
- 2023年广西投资集团有限公司校园招聘考试题库及答案解析
- 隧洞施工中不稳定围岩的分析及处理措施
- 专题1 两直线的位置关系(知识梳理与考点分类讲解)-2023-2024学年七年级数学下册专项突破讲与练(北师大版)
- 2023年合心人才发展集团幼儿园教师招聘考试真题
- 珠海市委政法委选调公务员笔试真题2023
- 第八章施工质量管理体系及措施
- 材料设备采购供应方案
- 北京版小学数学二年级上册全册教案
- PISA-阅读样题及点评
- 凝聚最大价值戴比尔斯——变卖钻石为卖爱情
- 昆明市小江寻甸县功山镇段治理工程环境影响报告书
- 你有多少种画平行线的方法---课件
- 人教版英语九年级Unit-1-全单元ppt课件(126页)
- 招聘求职简历制作表格模板可编辑下载 精品简历模板 空白标准表格03
- (精心整理)深圳小学英语语法汇总
- 部编二年级语文上册单元教材分析
- 部编版道德与法治四年级下册---全册教案(表格版)
评论
0/150
提交评论